Mastering the Art of Technology Transfer in Cell and Gene Therapy: Insights from Roberto Formisano of AGC Biologics”.

Advancements in technology transfer to a Contract Development and Manufacturing Organization

In an exclusive video interview, Roberto Formisano, Process Transfer Senior Manager at AGC Biologics, shares his insights on the challenges associated with technology transfer in the cell and gene therapy industry. He discusses the complexities involved in transferring technology from development to GMP manufacturing and from a customer to a contract development and manufacturing organization (CDMO).

Roberto highlights the critical timelines that present the biggest challenges in the field of technology transfer. He explains how balancing the number of batches that need to be manufactured is essential to ensuring sufficient and scientifically quality data within these timelines.

During his conversation with EPR editor Caroline Peachey at Terrapin’s Advanced Therapies conference in London on 19 March, Roberto delves into the nuances of technology transfer and its implications for the industry. He also shares his insights on the technology and manufacturing trends and priorities that he foresees for the cell and gene therapy industry in 2024.

Sophia Reynolds

As a content writer at, I'm always on the lookout for the next intriguing story to share with our audience. With a passion for crafting engaging and informative content, I delve into a variety of topics ranging from breaking news to feature pieces. My goal is to captivate readers through my words and keep them coming back for more. When I'm not typing away at my keyboard, you can find me exploring new coffee shops, diving into a good book, or taking long walks in nature. Join me on this journey of storytelling and discovery at - where every word has the power to inform and inspire.

Learn More →

Leave a Reply